Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, food and animal safety specialist Neogen
With that in mind, let's take a closer look at Neogen's business and see what CAPS investors are saying about the stock right now.
Neogen facts
| Headquarters (founded) | Lansing, Mich. (1981) |
| Market Cap | $1.0 billion |
| Industry | Health care supplies |
| Trailing-12-Month Revenue | $179.1 million |
| Management | Chairman/CEO James Herbert President/COO Lon Bohannon |
| Return on Equity (average, past 3 years) | 12.3% |
| Cash/Debt | $61.3 million / $0 |
| Competitors |
IDEXX Laboratories Life Technologies Strategic Diagnostics |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 97% of the 260 members who have rated Neogen believe the stock will outperform the S&P 500 going forward.
Just yesterday, one of those bulls, TMFNpugs, highlighted a few of the tailwinds working in the stock's favor: "New regulations (Food Safety Modernization Act), growing food imports, and more people with allergies will call for more widespread testing, this will benefit [Neogen]."
If you want market-topping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite a strong four-star rating, Neogen may not be your top choice.
If that's the case, we've compiled a special free report for investors called "Discover the Next Rule-Breaking Multibagger," which uncovers another small-cap growth play with big potential. The report is 100% free, but it won't be around forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.
